EPAS1 and von Hippel-Lindau disease: HIF-2α increases polyunsaturated lipids [14], and iron regulatory gene expressions, which in turn facilitates ferroptosis [15], but VHL (von hippel-lindau syndrome) mediates HIF-2α degradation leading to ferroptosis resistance [16].